DNAJC5 and malaria: The Walter Reed Army Institute of Research (WRAIR) has previously shown that TMV-based malaria vaccine candidates displaying a truncated (NPNAx5; T5) or extended (NPNAx20; T20) version of the major repeats or a junctional+minor repeat epitope (T51) were more protective than a soluble, nearly full-length CSP (FL-CSP) vaccine in a mouse transgenic parasite challenge model43,44.